Vázquez-Tsuji O, Cárdenas CR, Gómez SAL, Cardoso HG, Campos RT, Martínez-Barbabosa I, García CG

Idioma: Español
Referencias bibliográficas: 18
Paginas: 228-234
Archivo PDF: 245.58 Kb.

RESUMEN

Un niño con leucemia aguda linfoblástica desarrolló candidiasis hepato-espleno-renal. El paciente se encontraba en fase de inducción a la quimioterapia y cursaba con neutropenia.
Luego que se recuperó de esta última, presentó hepatoesplenomegalia con presencia de áreas hipoecoicas en hígado, bazo y riñones. Los hemocultivos resultaron positivos para Candida tropicalis con detección de antígeno manan, mediante anticuerpos monoclonales para Candida positiva. El paciente fue tratado con anfotericina B sin interrupción de su régimen de quimioterapia.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Walsh T. Management of immunocompromised patients with evidence of an invasive mycosis. Hem Onc Clin of NA 1993;7(5):1003-1025.

2. Verdeguer A, Fernandez J, Esquembre C, Ferris J, Ruis J, Castel B. Hepatosplenic candidiasis in children with acute leukemia. Cancer 1990;15:874-877.

3. Wright W, Wenzel R. Nosocomial Candida. Infectious. Dis Clin of NA 1997;2(11):411-442.

4. Stamos J, Rowley A. Candidemia in a pediatric population. Clin Infect Dis 1995;20: 571-575.

5. Anaissie E, Darouiche R, Abi-Said D, Uzun O, Mera J, Gentry L, Williams T, Kontoyiannis P, Karl C, Bodey G. Management of invasive candidal infection: Results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B. Clin Infect Dis 1996;23: 964-972.

6. Pizzo P, Walsh T. Fungal infections in the pediatric cancer patient. Sem in Onc Suppl 6 1990;17:6-9.

7. Antilla V, Elonen E, Nordiling. Hepatosplenic candidiasis in patients with acute leukemia: Incidence and prognostic implications. Clin Infect Dis 1997;24:375-380.

8. Thaler M, Pastakia B, Shawker T, O’Leary T, Pizzo P. Hepatic candidiasis in cancer patients: The envolving picture of the sindrome. Ann Inter Med 1988; 108: 88-100.

9. Sallah S, Semelka R, Whebie W, Nguyen N, Vos P. Hepatoesplenic candidiasis in patients with acute leukaemia. Brit J Haematol 1999;106:697-701.

10. Anaissie E, Bodey G, Kantarjian H, David C, Barnett K, Bow E, Defelice R, Downs N, File T, Karam G, Potts D, Shelton M, Sugar A. Fluconazole therapy for chronic disseminated candidiasis in patients whit leukemia and prior amphotericin B therapy. Am J Med 1991;91:142-150.

11. Kauffman C, Bradley S, Ross S, Weber D. Hepatoesplenic candidiasis: Successful treatment with fluconazol. Am J Med 1991;91:137-141.

12. Reiss E, de Repentigny L. Monoclonal antibodies against Candida tropicalis manan: antigen detection by enzyme immunoassay and immunofluorescence. J Clin Microbiol 1986;24:796-802.

13. Pastakia B, Shawker T, Thaler M, O’Leary T, Pizzo P. Hepatosplenic candidiasis heels within wheeles. Radiology 1988;166:417-421.

14. Walsh T, Whitcomb P, Revankar S, Pizzo P. Successful treatment of hepatoesplenic candidiasis through repeated cycles of chemotherapy and neutropenia. Cancer 1995;76:2337-2362.

15. Semelka R, Kelekis N, Sallah S, Worawattanakul S, Ascher S. Hepatoesplenic fungal disease: Diagnostic acuracy and spectrum of appearranceon MR imaging. ARJ 1997;169:1311-1316.

16. Shirkhoda A, López-Berestein G, Holbert J, Luna M. Hepatosplenic fungal infection: CT and pathologic evaluation after treatment with liposomal amphotericin B. Radiology 1996;159:349-353.

17. Edwards J. International conference for the development of a consensus on the management and preventions of severe candidial infections. Clin Infect Dis 1997;25:43-59.

18. Roilides E, Sein T, Schaufele R, Chanock S, Walsh T. Increased serum concentrations of interleukin 10 in patients with hepatosplenic candidiasis. J Infect Dis 1998;178:589-592.